Ellis Sean, a director at Entera Bio Ltd. ($ENTXW), made two open market purchases of common shares in the last 365 days, totaling $34,620. His most recent buy occurred on March 5, 2026. These purchases rank 3,331st among 4,983 individual insiders in our database, where the average buy amounts to $1.46 million across about 3.3 transactions. Ellis Sean reported no open market sales during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 5, 2026 | Entera Bio Ltd. | $ENTX | Ellis Sean | Director | P | Ordinary Shares, par value NIS 0.0000769 per share | 10000 | $1.23 | 188,098.0000 | 47,089,814 | 5.61% | 0.02% |
| Feb. 9, 2026 | Entera Bio Ltd. | $ENTX | Ellis Sean | Director | P | Ordinary Shares, par value NIS 0.0000769 per share | 18000 | $1.24 | 178,098.0000 | 47,089,814 | 11.24% | 0.04% |
| Jan. 1, 2026 | Entera Bio Ltd. | $ENTX | Ellis Sean | Director | A | Stock Option (right to buy) | 33505 | $0.00 | 33,505.0000 | 47,089,814 | 9999.99% | 0.07% |
| Jan. 1, 2026 | Entera Bio Ltd. | $ENTX | Ellis Sean | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 25371 | $0.00 | 160,098.0000 | 47,089,814 | 18.83% | 0.05% |
| Jan. 15, 2025 | Entera Bio Ltd. | $ENTX | Ellis Sean | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 7100 | $0.00 | 134,727.0000 | 37,650,179 | 5.56% | 0.02% |
| Jan. 15, 2025 | Entera Bio Ltd. | $ENTX | Ellis Sean | Director | A | Stock Option (right to buy) | 28509 | $0.00 | 28,509.0000 | 37,650,179 | 9999.99% | 0.08% |
| Oct. 2, 2024 | Entera Bio Ltd. | $ENTX | Ellis Sean | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 7466 | $0.00 | 127,627.0000 | 37,644,612 | 6.21% | 0.02% |
| Aug. 27, 2024 | Entera Bio Ltd. | $ENTX | Ellis Sean | Director | A | Ordinary Shares, par value NIS 0.0000769 per share | 18061 | $0.00 | 120,161.0000 | 29,007,794 | 17.69% | 0.06% |
| Jan. 1, 2024 | Entera Bio Ltd. | $ENTX | Ellis Sean | Director | A | Stock Option (right to buy) | 108333 | $0.00 | 108,333.0000 | 29,007,794 | 9999.99% | 0.37% |
| Aug. 21, 2023 | Entera Bio Ltd. | $ENTX | Ellis Sean | Director | P | Ordinary Shares, par value NIS 0.0000769 per share | 40000 | $0.60 | 102,100.0000 | 0 | 64.41% | 0.00% |
| Jan. 2, 2023 | Entera Bio Ltd. | $ENTX | Ellis Sean | Director | A | Stock Option (right to buy | 89041 | $0.00 | 89,041.0000 | 0 | 9999.99% | 0.00% |